HEIDI SAHLMAN

Contact info

Research groups - UEF

• 
  KuBiCo - Kuopio Birth Cohort Research
• 
  Toxicology Research Group

Publications

• von Hellens, Hetti; Keski-Nisula, Leea; Sahlman, Heidi. 2021. Increased risk of preeclampsia after use of paracetamol during pregnancy - causal or coincidence? Bmc pregnancy and childbirth 21 1: 24. 2021
• Lintula, Aino; Keski-Nisula, Leea; Sahlman, Heidi. 2020. Hypothyroidism and the increased risk of preeclampsia - interpretative factors? Hypertension in pregnancy 39 4: 411-417. 2020
• Mohammed, Ali Mustafa; Huuskonen, Pasi; Juvonen, Risto; Sahlman, Heidi; Repo, Jenni; Myöhänen, Kirsi; Myllynen, Päivi; Woo, Chit-Shing Jackson; Karttunen, Vesa; Vähäkangas, Kirsi. 2020. Activities of metabolizing enzymes in human placenta Toxicology letters 326: 70-77. 2020
• Biomarkers of Toxicity in Human Placenta [Chapter 18]. Vähäkangas, Kirsi; Loikkanen, Jarkko; Sahlman, Heidi; Karttunen, Vesa; Repo, Jenni; Sieppi, Elina; Kummu, Maria; Huuskonen, Pasi; Myöhänen, Kirsi; Storvik, Markus; Pasanen, Markku; Myllynen, Päivi; Pelkonen, Olavi / Biomarkers in Toxicology (Second edition). 2019. 2019
• Sahlman, H; Koponen, M; El-Nezami, H; Vahakangas, K; Keski-Nisula, L. 2019. Maternal use of drugs and preeclampsia British journal of clinical pharmacology 85 12: 2848-2855. 2019
• Karttunen Vesa, Sahlman Heidi, Repo Jenni K, Woo C.S.J, Myöhänen K, Myllynen Päivi, Vähäkangas Kirsi H. 2015. Criteria and challenges of the human placental perfusion - Data from a large series of perfusions. TOXICOLOGY IN VITRO 29 7: 1482-1491. 2015
• Vähäkangas Kirsi, Loikkanen Jarkko, Sahlman Heidi, Karttunen Vesa, Repo Jenni, Sieppi Elina, Kummu Maria, Huuskonen Pasi, Myöhänen Kirsi, Storvik Markus, Pasanen Markku, Myllynen Päivi, Pelkonen Olavi. 2014. Biomarkers of toxicity in human placenta [Chapter 20]: Gupta Ramesh C, Biomarkers in Toxicology. 325-360. 2014
• Mose T, Mathiesen L, Karttunen V, Nielsen JK, Sieppi E, Kummu M, Mørck TA, Myöhänen K, Partanen H, Vähäkangas K, Knudsen LE, Myllynen P. 2012. Meta-analysis of data from human ex vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris PLACENTA (LONDON) 33: 433-439. 2012
• Partanen Heidi, Vähäkangas Kirsi, Woo Chit SJ, Auriola Seppo, Veid Jenni, Chen Y, Myllynen Päivi, El Nezami Hani. 2012. Transplacental transfer of melamine PLACENTA (LONDON) 33: 60-66. 2012
• Partanen Heidi. 2012. Transplacental Transfer of Food Contaminants. Publications of the University of Eastern Finland. Dissertations in Health Sciences 110. 2012
• Woo Chit SJ, Partanen Heidi, Myllynen Päivi, Vähäkangas Kirsi, El-Nezami Hani. 2012. Fate of the teratogenic and carcinogenic ochratoxin A in human perfused placenta TOXICOLOGY LETTERS 208: 92-99. 2012
• Vähäkangas Kirsi, Veid Jenni, Karttunen Vesa, Partanen Heidi, Sieppi Elina, Kummu Maria, Myllynen Päivi, Loikkanen Jarkko. 2011. The significance of ABC transporters in human placenta for the exposure of the fetus to xenobiotics (Chapter 79). In: Ramesh, C. Gupta (ed.) Reproductive and Developmental Toxicology. Elsevier. s. 1051-1065. 2011
• Partanen HA, El-Nezami HS, Leppänen JM, Myllynen PK, Woodhouse HJ & Vähäkangas KH. 2010. Aflatoxin B1 transfer and metabolism in human placenta. TOXICOLOGICAL SCIENCES 113 1: 216 - 225. 2010
• Annola K, Heikkinen AT, Partanen H, Woodhouse H, Segerbäck D, Vähäkangas K. 2009. Transplacental transfer of nitrosodimethylamine in perfused human placenta. PLACENTA (LONDON) 30: 277-283. 2009